A hybrid of two major Blomia tropicalis allergens as an allergy vaccine candidate.
Eduardo Santos da SilvaLorenz AglasCarina Silva PinheiroEmília M M de Andrade BelitardoElisânia Fontes SilveiraSara HuberRogério Tanan TorresMichael WallnerPeter BrizaPeter LacknerJosef LaimerLuis Gustavo C PachecoÁlvaro A CruzNeuza Maria Alcântara-NevesFatima FerreiraPublished in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2020)
BTH2 is a promising hybrid vaccine candidate for immunotherapy of Blomia allergy. However, further pre-clinical studies addressing its efficacy and safety are needed.
Keyphrases